BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,971,000 | +157.0% | 1,974,000 | +171.2% | 0.00% | +100.0% |
| Q1 2020 | $767,000 | -60.4% | 728,000 | -59.3% | 0.00% | -50.0% |
| Q4 2019 | $1,939,000 | +53.6% | 1,788,000 | +46.7% | 0.00% | +100.0% |
| Q3 2019 | $1,262,000 | -2.5% | 1,219,000 | +5.2% | 0.00% | 0.0% |
| Q2 2019 | $1,294,000 | +22.5% | 1,159,000 | +24.8% | 0.00% | 0.0% |
| Q1 2019 | $1,056,000 | -0.2% | 929,000 | -2.8% | 0.00% | 0.0% |
| Q4 2018 | $1,058,000 | -12.2% | 956,000 | -4.5% | 0.00% | 0.0% |
| Q3 2018 | $1,205,000 | +8.9% | 1,001,000 | +5.3% | 0.00% | 0.0% |
| Q2 2018 | $1,107,000 | -47.3% | 951,000 | -50.0% | 0.00% | -50.0% |
| Q1 2018 | $2,099,000 | +109.1% | 1,902,000 | +125.9% | 0.00% | +100.0% |
| Q2 2017 | $1,004,000 | +32.1% | 842,000 | +31.2% | 0.00% | +100.0% |
| Q1 2017 | $760,000 | +0.3% | 642,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $758,000 | – | 642,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|